Navegar por autor "Fernández Nuñez, Natalia"

A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab

2012- Antón Aparicio, Luis Miguel; Fernández Nuñez, Natalia; Roldán Corrales, Ana Milena; Alvarez García, Augusto

Carboplatin-Pemetrexed Combination in Elderly Patients with Advanced Non-Squamous Non Small Cell Lung Cancer (NS-NSCLC)

2015- Anido Herranz, Urbano; Fernández Nuñez, Natalia; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Covela Rúa, Marta [et al.]

Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer

2019- Anido Herranz, Urbano; Fernández Nuñez, Natalia; Afonso-Afonso, J.; Santome-Couto, L.; Medina-Colmenero, A.; [et al.]

Effect of central nervous system (CNS) metastases in a real-world multicenter cohort study of Spanish ALK-positive non-small cell lung cancer (NSCLC) patients (p)

2019- Angelats L; García Campelo, María del Rosario; Bernabe Caro R; Arriola Aperribay E; Calvo de Juan V; [et al.]

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation

2019- AGRASO BUSTO, SARA; VARELA POSE, VANESA; Fernández Nuñez, Natalia; Firvida Perez, Jose Luis; Santome, L.; [et al.]

Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy

2019- RUIZ BAÑOBRE, JUAN; Areses Manrique, María Carmen; Mosquera-Martinez, J.; Cortegoso Mosquera, Alexandra Sabela; Afonso-Afonso, F. J.; [et al.]

Micrornas as emerging biomarkers for micrometastasis detection in breast tumors

2012- Valladares Ayerbes, Manuel; Haz Conde, María del Mar; Blanco Calvo, Moisés; Antolín Novoa, Silvia; Antón Aparicio, Luis Miguel; [et al.]

Paclitaxel and Irinotecan in Platinum Refractory/Resistant Small Cell Lung Cancer: Final Analisis of One Galician Lung Cancer Group Experience

2015- Anido Herranz, Urbano; Fernández Nuñez, Natalia; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Covela Rúa, Marta; [et al.]

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

2020- García González, Jorge José; RUIZ BAÑOBRE, JUAN; Afonso Afonso, Francisco Javier; Amenedo-Gancedo, Margarita; Areses Manrique, María Carmen; [et al.]

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study.

2015- Afonso Afonso, Francisco Javier; Anido Herranz, Urbano; Fernández Nuñez, Natalia; García Mata, Jesús; Firvida Perez, Jose Luis; [et al.]

Using biologic knowledge to discover molecular correlations between human renal cell carcinoma pathways

2014- Valladares Ayerbes, Manuel; Antón Aparicio, Luis Miguel; Gómez Veiga, Francisco; Aparicio Gallego, Guadalupe; Medina Villaamil, Vanessa; [et al.]

Repositorio digital RUNA

Navegar por autor "Fernández Nuñez, Natalia"

A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab ﻿

Carboplatin-Pemetrexed Combination in Elderly Patients with Advanced Non-Squamous Non Small Cell Lung Cancer (NS-NSCLC) ﻿

Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer ﻿

Effect of central nervous system (CNS) metastases in a real-world multicenter cohort study of Spanish ALK-positive non-small cell lung cancer (NSCLC) patients (p) ﻿

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation ﻿

Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy ﻿

Micrornas as emerging biomarkers for micrometastasis detection in breast tumors ﻿

Paclitaxel and Irinotecan in Platinum Refractory/Resistant Small Cell Lung Cancer: Final Analisis of One Galician Lung Cancer Group Experience ﻿

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis ﻿

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study. ﻿

Role of erlotinib in treatment of advanced non-small cell lung cancer ﻿

Searching for circulating microRNAs in genitourinary tumors ﻿

The role of platinum compounds for the treatment of breast cancer ﻿

Using biologic knowledge to discover molecular correlations between human renal cell carcinoma pathways ﻿

A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab

Carboplatin-Pemetrexed Combination in Elderly Patients with Advanced Non-Squamous Non Small Cell Lung Cancer (NS-NSCLC)

Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer

Effect of central nervous system (CNS) metastases in a real-world multicenter cohort study of Spanish ALK-positive non-small cell lung cancer (NSCLC) patients (p)

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation

Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy

Micrornas as emerging biomarkers for micrometastasis detection in breast tumors

Paclitaxel and Irinotecan in Platinum Refractory/Resistant Small Cell Lung Cancer: Final Analisis of One Galician Lung Cancer Group Experience

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study.

Role of erlotinib in treatment of advanced non-small cell lung cancer

Searching for circulating microRNAs in genitourinary tumors

The role of platinum compounds for the treatment of breast cancer

Using biologic knowledge to discover molecular correlations between human renal cell carcinoma pathways